Literature DB >> 778262

Humoral immunity in experimental syphilis. II. The relationship of neutralizing factors in immune serum to acquired resistance.

N H Bishop, J N Miller.   

Abstract

Evidence for a humoral mechanism in immunity to experimental syphilis was provided by the demonstration of immune rabbit serum factor(s) capable of inactivating virulent Treponema pallidum, Nichols strain, in an in vitro-in vivo neutralization test. After intratesticular infection, rabbits were bled periodically and their resistance to reinfection was determined by challenge with T. pallidum. The results of challenge showed that resistance to reinfection begins to develop by 11 days after infection, becomes complete by 3 months, and persists for at least 2 years. In the neutralization test, a mixture of treponemal suspension and serum from the infected animals was incubated anaerobically at 34 degrees C and the virulence of the treponemes was determined by intradermal inoculation into normal rabbits. Complete inactivation of treponemes by immune serum required heat-stable and heat-labile (56 degrees C, 30 min) serum components and 16 hr of incubation, and was accelerated by pre-incubation of the treponemes for 4 hr with nonimmune serum but not by 100 mug/ml of added lysozyme. Serum-neutralizing activity, first demonstrable 1 month postinfection, was quantitated by a neutralizing endpoint (NEP). A relatively close quantitative correlation was shown between the development of resistance to symptomatic reinfection and the appearance and persistence of both TPI antibody and neutralizing serum factor(s). The nature of the serum factor(s), the mechanism of treponemal inactivation, and the application of the test in assessing the immune status are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 778262

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp. pallidum.

Authors:  Brandon T Leader; Karin Hevner; Barbara J Molini; Lynn K Barrett; Wesley C Van Voorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 2.  Syphilis: using modern approaches to understand an old disease.

Authors:  Emily L Ho; Sheila A Lukehart
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

3.  Contribution of rabbit leukocyte defensins to the host response in experimental syphilis.

Authors:  L A Borenstein; T Ganz; S Sell; R I Lehrer; J N Miller
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 4.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Murine monoclonal antibodies specific for virulent Treponema pallidum (Nichols).

Authors:  S M Robertson; J R Kettman; J N Miller; M V Norgard
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Purification and characterization of a cloned protease-resistant Treponema pallidum-specific antigen.

Authors:  T E Fehniger; A M Walfield; T M Cunningham; J D Radolf; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

7.  Experimental infection of man with rabbit-virulent Treponema paraluis-cuniculi.

Authors:  S Graves; J Downes
Journal:  Br J Vener Dis       Date:  1981-02

8.  Scanning electron microscopy of Treponema pallidum (Nichols strain) attached to cultured mammalian cells.

Authors:  T J Fitzgerald; P Cleveland; R C Johnson; J N Miller; J A Sykes
Journal:  J Bacteriol       Date:  1977-06       Impact factor: 3.490

9.  Treponemal infection specifically enhances node T-cell regulation of macrophage activity.

Authors:  D R Tabor; O Bagasra; R F Jacobs
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 10.  Surface antigens of the syphilis spirochete and their potential as virulence determinants.

Authors:  D R Blanco; J N Miller; M A Lovett
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.